anemia
Our data suggest that rHuEPO-beta correctable CAB-induced anemia occurs in 14.3% of prostate cancer patients after 6 months of therapy.
Our data suggest that <span class="gene" id="12820454-14-22-33">rHuEPO-beta</span> correctable CAB-induced <span class="disease" id="12820454-14-58-64">anemia</span> occurs in 14.3% of prostate cancer patients after 6 months of therapy.